David Botero

2.1k total citations
41 papers, 899 citations indexed

About

David Botero is a scholar working on Parasitology, Pathology and Forensic Medicine and Infectious Diseases. According to data from OpenAlex, David Botero has authored 41 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Parasitology, 13 papers in Pathology and Forensic Medicine and 10 papers in Infectious Diseases. Recurrent topics in David Botero's work include Parasitic infections in humans and animals (13 papers), Parasitic Infections and Diagnostics (8 papers) and Parasites and Host Interactions (8 papers). David Botero is often cited by papers focused on Parasitic infections in humans and animals (13 papers), Parasitic Infections and Diagnostics (8 papers) and Parasites and Host Interactions (8 papers). David Botero collaborates with scholars based in Colombia, United States and Portugal. David Botero's co-authors include Ana Flisser, Héctor H. Garcı́a, Vedantam Rajshekhar, A. Clinton White, Osvaldo Massaiti Takayanagui, Jon S. Friedland, Carlton A. Evans, Elsa Sarti, Victor C. W. Tsang and J. C. Allan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Microbiology Reviews and European Heart Journal.

In The Last Decade

David Botero

37 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Botero Colombia 11 643 387 385 248 105 41 899
Hélène Carabin United States 11 882 1.4× 592 1.5× 470 1.2× 270 1.1× 128 1.2× 13 1.0k
Guillermina Ávila Mexico 17 826 1.3× 526 1.4× 633 1.6× 194 0.8× 153 1.5× 38 1.1k
A.L. Willingham Zambia 12 725 1.1× 546 1.4× 395 1.0× 99 0.4× 54 0.5× 19 856
V. Kumar Belgium 12 319 0.5× 156 0.4× 310 0.8× 206 0.8× 53 0.5× 36 594
Elise M. O’Connell United States 16 170 0.3× 128 0.3× 381 1.0× 223 0.9× 156 1.5× 32 730
Sri S. Margono Japan 16 629 1.0× 427 1.1× 522 1.4× 165 0.7× 66 0.6× 33 849
A.F. Pétavy France 14 381 0.6× 200 0.5× 347 0.9× 143 0.6× 78 0.7× 53 642
Uffe Christian Braae Denmark 21 638 1.0× 401 1.0× 406 1.1× 127 0.5× 98 0.9× 51 920
M.E. Boa Tanzania 9 403 0.6× 309 0.8× 222 0.6× 64 0.3× 46 0.4× 12 536
Kirezi Kanobana Belgium 16 271 0.4× 170 0.4× 386 1.0× 181 0.7× 77 0.7× 28 713

Countries citing papers authored by David Botero

Since Specialization
Citations

This map shows the geographic impact of David Botero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Botero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Botero more than expected).

Fields of papers citing papers by David Botero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Botero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Botero. The network helps show where David Botero may publish in the future.

Co-authorship network of co-authors of David Botero

This figure shows the co-authorship network connecting the top 25 collaborators of David Botero. A scholar is included among the top collaborators of David Botero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Botero. David Botero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Echeverría, Luis Eduardo, et al.. (2025). Impact of early SGLT2 inhibitors prescription on acute decompensated heart failure outcomes: insights from a real-world setting. Revista Española de Cardiología (English Edition). 78(9). 780–788. 1 indexed citations
2.
Arrieta‐Ortiz, Mario L., Luis M. Rodriguez‐R, David Botero, et al.. (2021). The type VI secretion system of Xanthomonas phaseoli pv. manihotis is involved in virulence and in vitro motility. BMC Microbiology. 21(1). 14–14. 20 indexed citations
3.
Bautista, Daniel, Martha Cárdenas, David Botero, et al.. (2021). Comprehensive Time-Series Analysis of the Gene Expression Profile in a Susceptible Cultivar of Tree Tomato (Solanum betaceum) During the Infection of Phytophthora betacei. Frontiers in Plant Science. 12. 730251–730251. 5 indexed citations
4.
Botero, David, Jonathan M. Monk, Vivian Bernal‐Galeano, et al.. (2020). Genome-Scale Metabolic Model of Xanthomonas phaseoli pv. manihotis: An Approach to Elucidate Pathogenicity at the Metabolic Level. Frontiers in Genetics. 11. 837–837. 6 indexed citations
5.
Botero, David, et al.. (2018). Network Analyses in Plant Pathogens. Frontiers in Microbiology. 9. 35–35. 20 indexed citations
6.
7.
Agudelo‐Flórez, Piedad, David Botero, & Luis Palacio. (2005). Evaluación del método ELISA de punto para el diagnóstico de la cisticercosis humana y para estimar valores de prevalencia en una región endémica en Colombia.. Biomédica. 25(4). 488–488. 8 indexed citations
8.
Arboleda, Margarita, et al.. (2004). Efectos de la desparasitación comunitaria en la población infantil del área urbana de Apartadó, Colombia. 18(1). 51–59. 5 indexed citations
9.
Botero, David. (1994). An Overview of the Clinical Experience of Secnidazole in Giardiasis and Amoebiasis. Clinical Drug Investigation. 8(S1). 47–52.
10.
Botero, David, et al.. (1993). Short course albendazole treatment for neurocysticercosis in Columbia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 87(5). 576–577. 26 indexed citations
11.
Botero, David, Herbert B. Tanowitz, Louis M. Weiss, & Murray Wittner. (1993). TAENIASIS AND CYSTICERCOSIS. Infectious Disease Clinics of North America. 7(3). 683–698. 59 indexed citations
12.
Botero, David, et al.. (1991). Tratamiento de la amibiasis intestinal con secnidazol: Estudio de 100 casos con amibiasis Intestinal aguda no complicada. Revista Digital Palabra (Universidad Pontificia Bolivariana). 10(1). 49–53. 1 indexed citations
13.
Botero, David, et al.. (1985). Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.. PubMed. 63(4). 731–7. 15 indexed citations
14.
Botero, David, et al.. (1984). Intraocular Filaria, a Loaina Species, from Man in Colombia. American Journal of Tropical Medicine and Hygiene. 33(4). 578–582. 13 indexed citations
15.
Botero, David, et al.. (1982). Tratamiento de la neurocisticercosis con praziquantel en Colombia. Colombia medica. 13(1). 15–22. 2 indexed citations
16.
Botero, David, et al.. (1982). Tratamiento de teniasis y de himenolepiasis con praziquantel.. Colombia medica. 13(4). 131–134. 3 indexed citations
17.
Botero, David, et al.. (1982). Tratamiento con praziquantel en 6 casos de cisticercosis subcutanea y en un caso ocular. Colombia medica. 13(1). 23–25.
18.
Botero, David, et al.. (1982). Treatment of Cysticercosis with Praziquantel in Colombia. American Journal of Tropical Medicine and Hygiene. 31(4). 811–821. 86 indexed citations
19.
Botero, David. (1981). [Persistence of endemic intestinal parasitosis in Latin America].. PubMed. 90(1). 39–47. 2 indexed citations
20.
Botero, David. (1979). [Possibilities of controlling soil transmitted helminths by mass treatments (author's transl)].. PubMed. 34(1-2). 39–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélène Carabin Breakdown of academic impact, for papers by Guillermina Ávila Breakdown of academic impact, for papers by A.L. Willingham Breakdown of academic impact, for papers by V. Kumar Breakdown of academic impact, for papers by Elise M. O’Connell Breakdown of academic impact, for papers by Sri S. Margono Breakdown of academic impact, for papers by A.F. Pétavy Breakdown of academic impact, for papers by Uffe Christian Braae Breakdown of academic impact, for papers by M.E. Boa Breakdown of academic impact, for papers by Kirezi Kanobana
Rankless by CCL
2026